Yeast Arrest Suppositories (Wisconsin Pharmacal) – cGMP Violations (2019)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Yeast Arrest, Homeopathic Formula, Vaginal Support suppositories, packaged in a) 14-count carton (NDC 68093-0730-1 and 68093-0730-3), b) 28-count carton (NDC 68093-0730-2 and 68093-0730-4), Manufactured for: Vitanica, 12401 SW Leveton Drive, Tualatin, OR 97062.
Brand
Wisconsin Pharmacal Company, LLC
Lot Codes / Batch Numbers
Lot #: a) 81827, Exp 8/2020, 111872, Exp 11/2020, 41970, Exp 4/2021, 519104, Exp 5/2021, b) 81827, Exp 8/2020, 111872, Exp 11/2020, 41970, Exp 4/2021.
Products Sold
Lot #: a) 81827, Exp 8/2020; 111872, Exp 11/2020; 41970, Exp 4/2021; 519104, Exp 5/2021; b) 81827, Exp 8/2020; 111872, Exp 11/2020; 41970, Exp 4/2021.
Wisconsin Pharmacal Company, LLC is recalling Yeast Arrest, Homeopathic Formula, Vaginal Support suppositories, packaged in a) 14-count carton (ND due to cGMP violations. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
cGMP violations
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
OR
Page updated: Jan 7, 2026